20 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09124441 2024-04-01 2025-03-31 09124441 2025-03-31 09124441 2024-03-31 09124441 2023-04-01 2024-03-31 09124441 2024-03-31 09124441 2023-03-31 09124441 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 09124441 bus:Director3 2024-04-01 2025-03-31 09124441 core:WithinOneYear 2025-03-31 09124441 core:WithinOneYear 2024-03-31 09124441 core:ShareCapital 2025-03-31 09124441 core:ShareCapital 2024-03-31 09124441 core:RetainedEarningsAccumulatedLosses 2025-03-31 09124441 core:RetainedEarningsAccumulatedLosses 2024-03-31 09124441 bus:Director1 2024-04-01 2025-03-31 09124441 bus:SmallEntities 2024-04-01 2025-03-31 09124441 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09124441 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09124441 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09124441 bus:FullAccounts 2024-04-01 2025-03-31 09124441 bus:OrdinaryShareClass1 2025-03-31 09124441 bus:OrdinaryShareClass1 2024-03-31
COMPANY REGISTRATION NUMBER: 09124441
City Health Limited
Filleted Unaudited Financial Statements
31 March 2025
City Health Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
Current assets
Debtors
5
101,164
240,998
Cash at bank and in hand
735,274
798,155
---------
------------
836,438
1,039,153
Creditors: amounts falling due within one year
6
835,685
1,038,444
---------
------------
Net current assets
753
709
----
----
Total assets less current liabilities
753
709
----
----
Net assets
753
709
----
----
Capital and reserves
Called up share capital
7
1,803
1,759
Profit and loss account
( 1,050)
( 1,050)
-------
-------
Shareholders funds
753
709
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 23 December 2025 , and are signed on behalf of the board by:
Dr W F Hussain
Chairman
Company registration number: 09124441
City Health Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Little Horton Lane Medical Centre, 392 Little Horton Lane, Bradford, West Yorkshire, BD5 0NX.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover represents health related services supplied during the year, exclusive of Value Added Tax where this applies. Revenue is recognised at the point at which services are provided. Revenue from contracts is recognised on the basis of performance against criteria for the full year with adjustment being made at the end of the year for any under or over performance.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans fron banks.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 20 (2024: 23 ).
5. Debtors
2025
2024
£
£
Trade debtors
100,649
240,998
Other debtors
515
---------
---------
101,164
240,998
---------
---------
6. Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
50,472
243,122
Other creditors
785,213
795,322
---------
------------
835,685
1,038,444
---------
------------
7. Called up share capital
Issued, called up and fully paid
2025
2024
No.
£
No.
£
Ordinary shares of £ 0.01 each
180,347
1,803
175,916
1,759
---------
-------
---------
-------
At the end of the year the share capital of the company is represented by the following member practices.
2025 2024
£ £
New Otley Road Practice 116 110
Frizinghall Medical Centre 37 38
Manor Medical Practice 110 109
Park Grange Medical Centre 39 36
Parkside Medical Practice 44 44
Kensington Partnership 247 244
Picton medical Practice 98 96
Dr Gilkar & Partners 77 79
Kensington Street Surgery 42 44
Clarendon Medical centre 100 95
Peel Park Surgery 32 31
The Lister Surgery 45 41
The City Medical Practice 44 40
The Avicenna Medical Practice 88 85
Ashwell Medical Centre 95 86
Moor Park Medical Practice 30 30
Valley view Surgery 65 65
Dr Raja & Partners 45 43
Bradford Student Health 112 110
Bilton Medical Centre 61 61
Grange Medical Centre 71 71
Eccleshill Village Surgery 34 34
The Bradford Moor Practice 42 39
Thornbury Medical Practice 72 70
Primrose Surgery 58 56
------- -------
1,803 1,759
------- -------